Articles by M. T. Malecki (7)

Lack of association between polymorphisms in the gene encoding protein tyrosine phosphatase 1B (PTPN1) and risk of Type 2 diabetes

K. Wanic, M. T. Malecki, T. Klupa, J. H. Warram, J. Sieradzki and A. S. Krolewski

Diabetic Medicine 24 ( 6 ): 650 - 655 , 2007

Diabetic retinopathy in permanent neonatal diabetes due to Kir6.2 gene mutations: the results of a minimum 2-year follow-up after the transfer from insulin to sulphonylurea

T. Klupa, J. Skupien, B. Mirkiewicz-Sieradzka, A. Gach, A. Noczynska, M. Szalecki, E. Kozek, J. Sieradzki, W. Mlynarski and M. T. Malecki

Diabetic Medicine 26 ( 6 ): 663 - 664 , 2009

Liraglutide therapy in Prader-Willi syndrome

K. Cyganek, T. Koblik, E. Kozek, M. Wojcik, J. Starzyk and M. T. Malecki

Diabetic Medicine 28 ( 6 ): 755 - 756 , 2011

Osteoprotegerin gene polymorphism in diabetic Charcot neuroarthropathy

A. Korzon-Burakowska, J. Jakobkiewicz-Banecka, A. Fiedosiuk, N. Petrova, T. Koblik, M. Gabig-Ciminska, M. Edmonds, M. T. Malecki and G. Wegrzyn

Diabetic Medicine 29 ( 6 ): 771 - 775 , 2012

HbA1c-based diabetes diagnosis among patients with glucokinase mutation (GCK-MODY) is affected by a genetic variant of glucose-6-phosphatase (G6PC2)

M. Borowiec, W. Fendler, P. Dusatkova, K. Antosik, S. Pruhova, O. Cinek, M. Mysliwiec, P. Jarosz-Chobot, M. T. Malecki and W. Mlynarski

Diabetic Medicine 29 ( 11 ): 1465 - 1469 , 2012

Apolipoprotein M can discriminate HNF1A-MODY from Type 1 diabetes

S. A. Mughal, R. Park, N. Nowak, A. L. Gloyn, F. Karpe, H. Matile, M. T. Malecki, M. I. McCarthy, M. Stoffel and K. R. Owen

Diabetic Medicine 30 ( 2 ): 246 - 250 , 2013

Population-based estimates for double diabetes amongst people with glucokinase monogenic diabetes, GCK-MODY

W. Fendler, B. Małachowska, A. Baranowska-Jazwiecka, M. Borowiec, K. Wyka, M. T. Malecki, P. Jarosz-Chobot, M. Mysliwiec and W. Mlynarski

Diabetic Medicine 31 ( 7 ): 881 - 883 , 2014